Virtual Key Opinion Leader Event to Discuss NS002 for the Treatment of Anaphylaxis

Join Nasus Pharma for a virtual key opinion leader (KOL) event featuring Michael S. Blaiss, MD (Medical College of Georgia, Good Samaritan Health Center of Gwinnett) and Joel Brooks, DO, MPH (Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children’s Hospital), who will join company management to discuss the unmet need and current treatment landscape for anaphylaxis.